Trial-based Effectiveness & Cost-effectiveness of the Partner in Balance

Status Recruiting

Clinical Trial Summary

Rationale: Informal care is one of the most important sources of care for dependent elderly people. The Partner in Balance (PIB) intervention aims to prepare and support informal caregivers for their caregiving tasks. Long-term cost-effectiveness evidence is required to support reimbursement decision-making on this PIB program. The investigators hypothesize that 1) caregiver self-efficacy in intervention arm PiB is higher compared to the control arm of usual care; 2) care costs of participants in intervention arm are lower compared to the control arm of usual care. Objectives: The investigators aim to answer the following research questions: - What is the effect of PiB on caregiver self-efficacy compared to usual care? - What is the effect of PiB on caregiver and person with dementia total care costs compared to usual care? - What is the incremental cost-utility ratio of PiB compared to usual care? - What is the annual budget impact of PiB compared to usual care? Study design: Pragmatic, cluster randomised controlled trial. Study population: Informal caregivers of people with early-stage dementia who are community-dwelling and are receiving little or no dementia-related formal ADL-care Intervention: blended E-health informal caregiver support program with online psycho-education and behavioural modelling. It contains personalized goal setting, online modules with option for online communication with care professional, evaluation with care professional. Main study parameters/endpoints: Primary: self-efficacy. Cost-utility: EQ5D, RUD. Secondary: quality-of-life, caregiver burden Data collection: Measurements consist of questionnaires (total duration is approximately 1 hour; administered at home, via telephone, via email or other location if preferred by the participant; take place at baseline, 3, 6, 12 and 24 months).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05450146
Study type	Interventional
Source	Maastricht University
Contact	Sander Osstyn, MSc
Phone	+31 43 388 1137
Email	s.osstyn@maastrichtuniversity.nl
Status	Recruiting
Phase	N/A
Start date	April 1, 2022
Completion date	February 28, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05328115` - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease	Phase 1
Active, not recruiting	`NCT05785910` - Adaptation of the Uniform Data Set for Telematic Administration	N/A
Completed	`NCT06417333` - A Smart-wrist Band Connected Mobile Application for the Assessment and Management of Dementia Symptoms	N/A
Not yet recruiting	`NCT06264362` - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia	N/A
Recruiting	`NCT05633095` - The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia	N/A
Withdrawn	`NCT04942184` - STRATEGIES to Improve Memory in Alzheimer's Disease	N/A
Completed	`NCT03692988` - Dignity Therapy for Patients With Early Dementia and Their Family	N/A
Recruiting	`NCT06147479` - Cognitive Stimulation in Daily Activities for People Living With Early to Middle Stage Dementia	N/A
Enrolling by invitation	`NCT03772977` - The Brain Health Champion Study	N/A
Active, not recruiting	`NCT03661034` - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)	N/A
Recruiting	`NCT05343611` - Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People	N/A
Completed	`NCT05187117` - CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners	N/A
Recruiting	`NCT05673759` - Event-Related Potential (ERP) Components in Clinical Diagnosis
Completed	`NCT05102201` - Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes	N/A
Recruiting	`NCT04313582` - Feasibility of the SmartPrompt for Improving Everyday Function in Dementia	N/A
Recruiting	`NCT05504811` - FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease	N/A
Not yet recruiting	`NCT06444841` - Paper-Based and Smartphone-Based Memory Supports	N/A
Recruiting	`NCT05728801` - Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Recruiting	`NCT06455163` - Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers	N/A
Recruiting	`NCT05894954` - Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms